IL-10, but not IL-4, suppresses infection-stimulated bone resorption in vivo

Journal of Immunology

Volumn 165, Issue 7, 2000, Pages 3626-3630

  Sasaki, H ^a   Hou, L ^a   Belani, A ^a   Wang, C Y ^a   Uchiyama, T ^a   Muller R ^a   Stashenko, P ^a  

^a FORSYTH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 4;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DESTRUCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; IN VIVO STUDY; INFECTION; MACROPHAGE; MALE; MOUSE; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; TH2 CELL; TOMOGRAPHY; TOOTH PULP;

EID: 0034292422     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.7.3626     Document Type: Article

References (58)

1. An interleukin 1-like factor stimulates bone resorption in vitro
2. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors
3. The cellular actions of interleukin-on bone resorption in vitro
4. IL-6 is produced by osteoblasts and induces bone resorption
5. Endogenous bone-resorbing factors in estrogen deficiency: Cooperative effects of IL-1 and IL-6
6. The role of interleukin-1α in the pathogenesis of periapical bone destruction in a rat model system
7. Immunolocalization of bone-resorptive cytokines in rat pulp and periapical lesions following surgical pulp exposure
8. Bone-resorptive cytokine gene expression in periapical lesions in the rat
9. Periapical inflammatory responses and their modulation
10. IL-10 inhibits cytokine production by activated macrophages
11. Immunoregulatory properties of IL-13 in patients with inflammatory bowel disease; comparison with IL-4 and IL-10
12. Suppression by IL-10 and IL-4 of cytokine production induced by two-way autologous mixed lymphocyte reaction
13. Monocytes cultured in cytokine-defined environments differ from freshly isolated monocytes in their responses to IL-4 and IL-10
14. Interleukin (IL)-10 inhibits nuclear factor κB (NF-κB) activation in human monocytes: IL-10 and IL-4 suppress cytokine synthesis by different mechanisms
15. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties
16. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
17. Interleukin-4 modulates osteoclast differentiation and inhibits the formation of resorption pits in mouse osteoclast cultures
18. Interleukin-4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritis
19. 2+ in murine osteoclasts
20. IL-10 modulates formation of osteoclasts in murine hemopoietic cultures
21. Expression of bone-resorptive and regulatory cytokines in murine periapical inflammation
22. Infection-stimulated infraosseus inflammation and bone destruction is increased in P-/E-selectin knockout mice
23. Increased susceptibility of RAG-2 SCID mice to dissemination of endodontic infections
24. Quantification of periapical bone destruction in mice by micro-computed tomography
25. Pathogenesis of induced rat periapical lesions
26. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice
27. IL-10 attenuates excessive inflammation in chronic Pseudomonas infection in mice
28. Staphylococcus aureus-induced septic arthritis and septic death is decreased in IL-4-deficient mice: Role of IL-4 as promoter for bacterial growth
29. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregalatory role of IL-10 produced by monocytes
30. Depletion of endogenous interleukin-10 augments interleukin-1β secretion by Mycobacterium bovis BCG-reactive human cells
31. Modified immunological status of anti-IL-10 treated mice
32. Interleukin-4 inhibits the expression of tumour necrosis factors-α and -β, interleukins-1β and -6 and interferon-γ
33. IL-4 down-regulates IL-2-, IL-3-, and GM-CSF-induced cytokine gene expression in peripheral blood monocytes
34. Interleukin (IL)-4 differentially regulates monocyte IL-1 family gene expression and synthesis in vitro and in vivo
35. IL-1 expression in human monocytes is transcriptionally and posttranscriptionally regulated by IL-4
36. Interleukin-4 suppresses inflammatory cytokine gene transcription in porcine macrophages
37. Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease
38. Cutting edge: Clustered AU-rich elements are the target of IL-10-mediated mRNA destabilization in mouse macrophages
39. IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells
40. IL-4-induced expression of the IL-1 receptor antagonist gene is mediated by STAT6
41. Interleukin-10 differentially regulates cytokine inhibitor and chemokine release from blood mononuclear cells and fibroblasts
42. IL-10 induces DNA binding activity of three STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genes
43. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils
44. Interleukin-1β is a potent inhibitor of bone formation in vitro
45. IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts
46. Inhibition of tumor necrosis factor-α-induced prostaglandin E2 production by the antiinflammatory cytokines interleukin-4, interleukin-10, and interleukin-13 in osteoarthritic synovial fibroblasts: Distinct targeting in the signaling pathways
47. Interleukin 4 inhibits murine osteoclast formation in vitro
48. Inhibitory effect of interleukin-4 on osteoclast-like cell formation in mouse bone marrow culture
49. Interleukin-10 selectively inhibits osteoclastogenesis by inhibiting differentiation of osteeclast progenitors into preosteoclast-like cells in rat bone marrow culture system
50. IL-10 inhibits prostaglandin E2 production by llpopolysaccharide-stimulated monocytes
51. IL-6 and APPs: Antiinflammatory and immunosuppressive mediators
52. Stimulation by interleukin-1 of interleukin-6 production by human periodontal ligament cells
53. Interieukin-1 induces interleukin-6 production in peripheral blood monocytes
54. Induction of interleukin 6 by human and murine recombinant interleukin 1 in mice
55. Subchronic glucocorticoid pretreatment reversibly attenuates IL-β induced fever in rats; IL-6 mRNA is elevated while IL-1α and IL-1β mRNAs are suppressed, in the CNS
56. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF
57. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: Induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55
58. Neutralization of endogenous IL-6 suppresses induction of IL-1 receptor antagonist